Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers' Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
Steven R. HouserTemple University School of MedicineNoneNoneNoneNoneNoneNoneNone
Kenneth B. MarguliesUniversity of PennsylvaniaNoneNoneNoneNoneNoneNoneNone
Gary S. FrancisUniversity of MinnesotaNoneNoneNoneNoneNoneNoneNone
David A. KassJohns Hopkins University School of MedicineNoneNoneNoneNoneNoneNoneNone
Walter J. KochThomas Jefferson UniversityNoneNoneNoneNoneNoneNoneNone
Jeffrey D. MolkentinHoward Hughes Medical Institute/Children's Hospital Medical CenterNoneNoneNoneNoneNoneNoneNone
Anne M. MurphyJohns Hopkins UniversityThe Cardiovascular Medical Research and Education Fund*; NIHNoneNoneNoneSold stock of Merck and Pfizer (jointly owned) in Dec 2009*NoneNone
Sumanth D. PrabhuThe University of Alabama at BirminghamAbiomed; NIH/NHLBI/NCRR; SCR Inc.; VANoneThoratec Corp*NoneNoneSCR, Inc.*None
Howard A. RockmanDuke UniversityNoneNoneNoneNoneTrevena Inc.*Trevena Inc.None
Francis G. SpinaleUniversity of South Carolina School of MedicineNoneNoneNoneNoneNoneNoneNone
Mark A. SussmanSan Diego State UniversityNoneNoneNoneNoneFounder and Chief Scientific Officer of CardioCreate Inc.NoneNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.